Page last updated: 2024-08-17

aldosterone and tak 044

aldosterone has been researched along with tak 044 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukai, D; Kinoshita, M; Ohnishi, M; Tsutamoto, T; Wada, A1
Fukai, N; Hirata, Y; Ozawa, N; Sato, R; Shichiri, M; Sugiyama, T; Yoshimoto, T1

Other Studies

2 other study(ies) available for aldosterone and tak 044

ArticleYear
Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Cardiovascular research, 1998, Volume: 39, Issue:3

    Topics: Aldosterone; Analysis of Variance; Animals; Atrial Natriuretic Factor; Azepines; Cardiac Pacing, Artificial; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Indoles; Kidney; Male; Peptides, Cyclic; Receptor, Endothelin A; Renal Plasma Flow; Sodium

1998
Endothelin-1 induces cyclooxygenase-2 expression and generation of reactive oxygen species in endothelial cells.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Aldosterone; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Induction; Flavonoids; Indoles; Male; Maleimides; Mitogen-Activated Protein Kinase Kinases; Nitrobenzenes; Peptides, Cyclic; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Endothelin; RNA, Messenger; Sulfonamides

2004